Cargando…
Diagnostic Accuracy of a Prototype Point-of-Care Test for Ocular Chlamydia trachomatis under Field Conditions in The Gambia and Senegal
BACKGROUND: The clinical signs of active trachoma are often present in the absence of ocular Chlamydia trachomatis infection in low prevalence and mass treated settings. Treatment decisions are currently based on the prevalence of clinical signs, and this may result in the unnecessary distribution o...
Autores principales: | Harding-Esch, Emma M., Holland, Martin J., Schémann, Jean-François, Molina, Sandra, Sarr, Isatou, Andreasen, Aura A., Roberts, Chrissy h., Sillah, Ansumana, Sarr, Boubacar, Harding, Edward F., Edwards, Tansy, Bailey, Robin L., Mabey, David C. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149007/ https://www.ncbi.nlm.nih.gov/pubmed/21829735 http://dx.doi.org/10.1371/journal.pntd.0001234 |
Ejemplares similares
-
Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019) -
Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009) -
Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015) -
Facial cleanliness indicators by time of day: results of a cross-sectional trachoma prevalence survey in Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2020) -
Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)